Literature DB >> 29943183

Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer.

Ji Hye Min1,2, Tae Wook Kang3, Dong Ik Cha1, Seong Hyun Kim1, Kyung Sook Shin2, Jeong Eun Lee2, Kee-Taek Jang4, Soo Hyun Ahn5.   

Abstract

OBJECTIVES: To evaluate the correlation between tumour differentiation or stage of gallbladder cancer (GBC) and the apparent diffusion coefficient (ADC), as well as to assess whether ADC value can predict long-term disease-free survival (DFS) after surgery.
METHODS: This retrospective study was approved by the institutional review board and the requirement for informed consent was waived. Between March 2008 and June 2016, 79 patients who underwent magnetic resonance (MR) imaging with diffusion-weighted image and subsequent surgery for GBC were included in this study. Correlations between quantitative ADC values and tumour differentiation or stage based on the American Joint Committee on Cancer (AJCC) were assessed using Spearman's correlation analysis. Prognostic factors for DFS were identified with multivariate Cox regression analysis using imaging and clinical characteristics.
RESULTS: All patients were classified as having well- (n = 18), moderately (n = 35) or poorly differentiated GBCs (n = 26). The ADC value of GBCs was significantly correlated with tumour differentiation and AJCC stage (p < 0.001 and p < 0.001, respectively). Sixty-nine patients were followed up for 2.0-92.4 months (median, 23.5 months). On multivariate analysis, the significant prognostic factor for DFS was not tumour differentiation or AJCC stage but a binary tumour ADC value (hazard ratio, 4.29; p = 0.009). DFS rates were significantly different according to the classification of tumour ADC value (cut-off value = 1.04 × 10-3 mm2/s; p = 0.004).
CONCLUSION: The ADC value of GBCs was significantly correlated with tumour differentiation as well as AJCC stage. In addition, it predicted long-term outcomes after surgery in patients with GBC. KEY POINTS: • ADC values of GBC and tumour differentiation were negatively correlated. • Lower ADC values of GBC were significantly correlated with higher tumour stage. • Tumour ADC value could be useful for risk stratification of GBC patients.

Entities:  

Keywords:  Diffusion; Gallbladder neoplasms; Magnetic resonance imaging; Treatment outcome

Mesh:

Year:  2018        PMID: 29943183     DOI: 10.1007/s00330-018-5602-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  29 in total

1.  Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?

Authors:  Hiroki Haradome; Luigi Grazioli; Mika Tsunoo; Rita Tinti; Barbara Frittoli; Sebastiana Gambarini; Mario Morone; Utaroh Motosugi; Stefano Colagrande
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

2.  Estimation of the Youden Index and its associated cutoff point.

Authors:  Ronen Fluss; David Faraggi; Benjamin Reiser
Journal:  Biom J       Date:  2005-08       Impact factor: 2.207

3.  High b-value diffusion-weighted MRI in differentiation between benign and malignant polypoid gallbladder lesions.

Authors:  Hiroyuki Irie; Noriyuki Kamochi; Junichi Nojiri; Yoshiaki Egashira; Kohei Sasaguri; Sho Kudo
Journal:  Acta Radiol       Date:  2011-03-03       Impact factor: 1.990

4.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

Review 5.  Gallbladder carcinoma: radiologic-pathologic correlation.

Authors:  A D Levy; L A Murakata; C A Rohrmann
Journal:  Radiographics       Date:  2001 Mar-Apr       Impact factor: 5.333

Review 6.  Gallbladder cancer.

Authors:  D L Bartlett
Journal:  Semin Surg Oncol       Date:  2000 Sep-Oct

7.  "Extended" radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations.

Authors:  Yoshio Shirai; Jun Sakata; Toshifumi Wakai; Taku Ohashi; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

8.  Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

Authors:  Tadahiro Takada; Hodaka Amano; Hideki Yasuda; Yuji Nimura; Takashi Matsushiro; Hiroyuki Kato; Takukazu Nagakawa; Toshimichi Nakayama
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

9.  Prognostic factors for gallbladder cancer in Japan.

Authors:  Masato Kayahara; Takukazu Nagakawa; Hisatoshi Nakagawara; Hirohisa Kitagawa; Tetsuo Ohta
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

10.  Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.

Authors:  D E Henson; J Albores-Saavedra; D Corle
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

View more
  3 in total

1.  Preoperative CT findings for prediction of resectability in patients with gallbladder cancer.

Authors:  Seo-Youn Choi; Jung Hoon Kim; Hyun Jeong Park; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-06-28       Impact factor: 5.315

2.  Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer.

Authors:  Jiasheng Cao; Yong Wang; Bin Zhang; Jiahao Hu; Win Topatana; Shijie Li; Sarun Juengpanich; Ziyi Lu; Xiujun Cai; Mingyu Chen
Journal:  Front Oncol       Date:  2021-10-28       Impact factor: 6.244

3.  Differentiating benign from malignant gallbladder wall thickening in non-contrast MRI imaging: Preliminary study of a combined diagnostic indicator.

Authors:  Wen-Wen He; Jian-Guo Zhu; Dmytro Pylypenko; Fei Liu; Mei Wang; Yue-Fei Wu; Jun Tian; Hai-Ge Li
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.